You have 9 free searches left this month | for more free features.

direct Xa inhibition

Showing 1 - 25 of 9,876

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coagulation Disorder Trial (PROTHROMPLEX TOTAL, 4F-PCC)

Not yet recruiting
  • Coagulation Disorder
  • (no location specified)
Jul 14, 2022

Traumatic Brain Injury Trial (transcranial direct current stimulation, transcranial pulsed current stimulation, Sham-no

Withdrawn
  • Traumatic Brain Injury
  • transcranial direct current stimulation
  • +2 more
  • (no location specified)
Dec 13, 2021

Low Back Pain Trial in Aalborg (High-Definition Transcranial Direct Current Stimulation)

Completed
  • Low Back Pain
  • High-Definition Transcranial Direct Current Stimulation
  • Aalborg, Denmark
    CNAP, SMI, Aalborg University
Dec 10, 2020

Anticoagulation in Patients on ECMO for Severe Lung Failure

Completed
  • ARDS
  • COVID-19
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Sep 18, 2023

SCAD, AMI Trial in Sao Paulo (ASA, Clopidogrel, Edoxaban)

Recruiting
  • SCAD
  • AMI
  • Sao Paulo, Brazil
    Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Fac
Nov 4, 2021

Rivaroxaban - Percutaneous Coronary Intervention

Completed
  • Coronary Artery Disease
  • Atrial Fibrillation
  • In vitro heparin
  • Bursa, Turkey
    Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Sep 13, 2022

Bleeding Trial in Worldwide (Andexanet)

Completed
  • Bleeding
  • Andexanet
  • Long Beach, California
  • +86 more
Jan 25, 2022

Sickle Cell Anemia, Sickle Cell-Beta0-Thalassemia Trial in Chapel Hill (rivaroxaban, )

Completed
  • Sickle Cell Anemia
  • Sickle Cell-Beta0-Thalassemia
  • Chapel Hill, North Carolina
    University of North Carolina - Chapel Hill
Apr 9, 2020

Specific PoC Testing of Coagulation in Patients Treated With

Recruiting
  • Anticoagulation With NOAC
  • anti-Xa activity point-of-care testing (aXa-POCT)
  • ecarin clotting time point-of-care testing (ECT-POCT)
  • Tuebingen, Germany
    University Hospital Tuebingen
Dec 14, 2020

Hypothermia and Acidosis on Coagulation During Treatment With

Recruiting
  • Trauma
  • +3 more
  • Rivaroxaban 15 MG
  • Lund, Skåne, Sweden
    Skåne University Hospital
Dec 30, 2022

Urin-based Point-of-Care Testing for Direct Oral Anticoagulants

Recruiting
  • Stroke
  • Urin-based test by the DOASENSE Dipstick Device
  • Gießen, Hesse, Germany
    Department of Neurology, University Hospital Giessen
Sep 13, 2023

CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )

Active, not recruiting
  • CTEPH
  • Fukuoka, Japan
    Kyushu University Hospital
Aug 30, 2022

Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19

Completed
  • Critical Illness
  • +2 more
  • blood sampling
  • Arnhem, Netherlands
    Monique de Maat
Jun 28, 2023

Antiphospholipid Syndrome, Anticoagulant Drugs Trial in Clermont-Ferrand (Lupus anticoagulant testing)

Recruiting
  • Antiphospholipid Syndrome
  • Anticoagulant Drugs
  • Lupus anticoagulant testing
  • Clermont-Ferrand, France
    CHU clermont-ferrand
Jun 13, 2022

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Brain Connectivity Between Networks Implied in Inhibition and

Not yet recruiting
  • Alcohol Use Disorder
  • Go-Nogo-task during functional magnetic resonance imaging
  • Resting-state functional magnetic resonance imaging
  • Bern, Switzerland
    University Hospital for Psychiatry and Psychotherapy Bern
Apr 24, 2023

Spinal Cord Injuries Trial in Istanbul (Tendon tap, Tibial nerve stimulation)

Completed
  • Spinal Cord Injuries
  • Tendon tap
  • Tibial nerve stimulation
  • Istanbul, Turkey
    İstanbul Physical Therapy Training and Research Hospital
Aug 11, 2023

Chronic Renal Failure Trial in Valinhos (Heparin sodic, heparin liquemine)

Suspended
  • Chronic Renal Failure
  • Heparin sodic
  • heparin liquemine
  • Valinhos, Sao Paulo, Brazil
    Lal Clinica Pesquisa E Desenvolvimento Ltda
Nov 1, 2022

Stroke, Paresis, Upper Extremity Paralysis Trial in Rome (Real dual tDCS + Robotic Arm Therapy, SHAM tDCS + Robotic Arm Therapy)

Completed
  • Stroke
  • +2 more
  • Real dual tDCS + Robotic Arm Therapy
  • SHAM tDCS + Robotic Arm Therapy
  • Rome, Italy
  • +1 more
Jul 7, 2022

Venous Thromboembolism Trial in Russian Federation (Dimolegin 40 mg, Dimolegin 60 mg, Fragmin)

Active, not recruiting
  • Venous Thromboembolism
  • Dimolegin 40 mg
  • +2 more
  • Bryansk, Russian Federation
  • +14 more
Apr 25, 2022

Interference Between Oral Anticoagulants and Heparin During

Recruiting
  • Atrial Fibrillation
  • Atrial Tachycardia
    • Paris, France
      Hopital Bichat-Claude Bernard
    Mar 27, 2023

    Aortic Valve Disease Trial in Paris (Apixaban 5 MG Oral Tablet, warfarin with an objective of INR target of 2.5 (range:

    Not yet recruiting
    • Aortic Valve Disease
    • Apixaban 5 MG Oral Tablet
    • warfarin with an objective of INR target of 2.5 (range: 2.0-3.0)
    • Paris, France
      Service de Cardiologie Hôpital Lariboisière
    Jan 24, 2023

    Health Care Interventions and Outcomes of Major Bleedings in

    Not yet recruiting
    • Major Bleeding
    • None (Observational study)
    • (no location specified)
    Nov 17, 2023

    Binge Drinking Trial in Braga (Active tDCS, Sham tDCS, Active CT)

    Completed
    • Binge Drinking
    • Active tDCS
    • +3 more
    • Braga, Portugal
      School of Psychology
    Nov 2, 2022

    Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])

    Not yet recruiting
    • Liver Cirrhosis
    • Apixaban 5 MG [Eliquis]
    • Edoxaban 60 MG [Lixiana]
    • (no location specified)
    May 19, 2023